Synthesis and anticancer activity of benzyloxybenzaldehyde derivatives against HL-60 cells
[Display omitted] A series of benzyloxybenzaldehyde derivatives were prepared and tested against the HL-60 cell line for anticancer activity. Preliminary structure–activity relationships were established. It was discovered that 2-(benzyloxy)benzaldehyde ( 17), 2-(benzyloxy)-4-methoxybenzaldehyde ( 2...
Saved in:
Published in | Bioorganic & medicinal chemistry Vol. 13; no. 5; pp. 1537 - 1544 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford
Elsevier Ltd
01.03.2005
Elsevier Science |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | [Display omitted]
A series of benzyloxybenzaldehyde derivatives were prepared and tested against the HL-60 cell line for anticancer activity. Preliminary structure–activity relationships were established. It was discovered that 2-(benzyloxy)benzaldehyde (
17), 2-(benzyloxy)-4-methoxybenzaldehyde (
26), 2-(benzyloxy)-5-methoxybenzaldehyde (
27), 2-(benzyloxy)-5-chlorobenzaldehyde (
28), 2-[(3-methoxybenzyl)oxy]benzaldehyde (
29), 2-[(2-chlorobenzyl)oxy]benzaldehyde (
30), and 2-[(4-chlorobenzyl)oxy]benzaldehyde (
31) exhibited significant activity at 1–10
μM. Among them, compound
29 was the most potent one. The morphological assessment and DNA fragmentation analysis indicated that these compounds arrested cell cycle progression at G2/M phase and induced cell apoptosis. They resulted in the loss of mitochondrial membrane potential after 12
h of treatment. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0968-0896 1464-3391 |
DOI: | 10.1016/j.bmc.2004.12.026 |